Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vahram Haroutunian

Showing results (1-10 of 270) with videos related to

Pageof 27
Sort By:
Frontiers in Cellular Neuroscience|January 31, 2014
Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalitiesPanos Roussos, Vahram Haroutunian
Brain Pathology (Zurich, Switzerland)|October 9, 2007
Autism brain tissue bankingVahram Haroutunian, Jane Pickett
Dialogues in Clinical Neuroscience|October 15, 2019
Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-oldPavel Katsel, Vahram Haroutunian
Lancet (London, England)|September 19, 2003
Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorderKenneth L Davis, Vahram Haroutunian
The International Journal of Neuropsychopharmacology|June 23, 2007
Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophreniaVahram Haroutunian, Kenneth L Davis
Pharmacology, Biochemistry, and Behavior|January 16, 2004
p-Chloroamphetamine blocks physostigmine-induced memory enhancement in rats with unilateral nucleus basalis lesionsAnthony C Santucci, Vahram Haroutunian
Current Psychiatry Reports|July 20, 2002
Issues and perspectives on brain tissue bankingVahram Haroutunian, Kenneth L Davis
Schizophrenia Research|April 20, 2023
Lower levels of cortical [<sup>3</sup>H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficitsBrian Dean, Vahram Haroutunian, Elizabeth Scarr
Plos One|October 30, 2009
Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individualsPavel Katsel, Weilun Tan, Vahram Haroutunian
Neurochemical Research|March 8, 2007
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?Pavel Katsel, Celeste Li, Vahram Haroutunian
Pageof 27

Showing results (1-10 of 270) with videos related to

Sort By:
Pageof 27
Frontiers in Cellular Neuroscience|January 31, 2014
Schizophrenia: susceptibility genes and oligodendroglial and myelin related abnormalitiesPanos Roussos, Vahram Haroutunian
Brain Pathology (Zurich, Switzerland)|October 9, 2007
Autism brain tissue bankingVahram Haroutunian, Jane Pickett
Dialogues in Clinical Neuroscience|October 15, 2019
Is Alzheimer disease a failure of mobilizing immune defense? Lessons from cognitively fit oldest-oldPavel Katsel, Vahram Haroutunian
Lancet (London, England)|September 19, 2003
Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorderKenneth L Davis, Vahram Haroutunian
The International Journal of Neuropsychopharmacology|June 23, 2007
Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophreniaVahram Haroutunian, Kenneth L Davis
Pharmacology, Biochemistry, and Behavior|January 16, 2004
p-Chloroamphetamine blocks physostigmine-induced memory enhancement in rats with unilateral nucleus basalis lesionsAnthony C Santucci, Vahram Haroutunian
Current Psychiatry Reports|July 20, 2002
Issues and perspectives on brain tissue bankingVahram Haroutunian, Kenneth L Davis
Schizophrenia Research|April 20, 2023
Lower levels of cortical [<sup>3</sup>H]pirenzepine binding to postmortem tissue defines a sub-group of older people with schizophrenia with less severe cognitive deficitsBrian Dean, Vahram Haroutunian, Elizabeth Scarr
Plos One|October 30, 2009
Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individualsPavel Katsel, Weilun Tan, Vahram Haroutunian
Neurochemical Research|March 8, 2007
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?Pavel Katsel, Celeste Li, Vahram Haroutunian
Pageof 27